What would happen in the event of a deadly new strain of influenza? Dr. Jack Regan discusses the importance of open-access diagnostics in pandemic prevention.
Pandemic byline in Hospital & Healthcare
LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.
No events in this category to show at this time.
LexaGene’s MiQLab™ System, a TRL-7 technology, drastically shortens the time gap between novel pathogen identification and point-of-need testing through its open-access feature.